Meet Amazon’s New Line of Skincare Products

Amazon in its quest for total world domination has now released a line of high-quality skincare products that offer solutions for various skin types and feature ingredients with proven effectiveness.

Published March 20, 2019, 10:40am ET · 1 min read

A close-up shot of the Amazon app icon on a blue digital screen, showing visible pixels. The icon is a rounded square, with the top section white displaying the black 'amazon' logo and an orange smile-shaped arrow beneath it. The bottom section of the icon is blue with a white shopping cart symbol and two white dots representing wheels. Below the app icon, the word 'Amazon' is visible in white text.
The Amazon app icon symbolizes the e-commerce giant's strong position in the market, often considered a significant player in the digital economy. © Muhla1 / Getty Images

Amazon.com Inc. (NASDAQ: AMZN | AMZN Price Prediction) in its quest for total world domination has now released a line of high-quality skincare products that offer solutions for various skin types and feature ingredients with proven effectiveness.

The collection has 12 different items, including everything from retinol moisturizer to vitamin C serums, to help customers address common skincare concerns like acne, the appearance of fine lines and wrinkles, dark spots, dehydration, dullness and more.

The firm was quick to note that all Belei products are free of parabens, phthalates, sulfates and fragrance, and they are not tested on animals. Also, Belei product bottles are made of post-consumer recycled resin and carton packaging is 100% recyclable.

[nativounit]

Kara Trousdale, head of Beauty for Private Brands on Amazon, commented:

Our goal is to help customers spend less time and money searching for the right skincare solutions. We took a simple, no-nonsense approach when creating Belei, developing products with ingredients that are both proven to deliver results and also offer customers great value for the quality.

Shares of Amazon were last seen at $1,773.67, in a 52-week range of $1,307.00 to $2,050.50. The consensus price target is $2080.05.

[recirclink id=535587]

[wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

All articles →